Zunveyl (benzgalantamine)—a better-tolerated version of the Alzheimer’s drug Razadyne (galantamine)—is expected to be available in U.S. pharmacies by the end of March.
The drug was approved by the Food and Drug Administration (FDA) in July 2024 for people with mild to moderate…
An Improved Alzheimer’s Drug With Fewer Side Effects Will Be Available Soon …C0NTINUE READING >>>>